Caribou Biosciences (CRBU) Operating Income: 2020-2025
Historic Operating Income for Caribou Biosciences (CRBU) over the last 6 years, with Sep 2025 value amounting to -$29.4 million.
- Caribou Biosciences' Operating Income rose 23.11% to -$29.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$158.8 million, marking a year-over-year increase of 3.88%. This contributed to the annual value of -$166.6 million for FY2024, which is 43.56% down from last year.
- According to the latest figures from Q3 2025, Caribou Biosciences' Operating Income is -$29.4 million, which was up 38.21% from -$47.6 million recorded in Q2 2025.
- Over the past 5 years, Caribou Biosciences' Operating Income peaked at -$13.2 million during Q1 2021, and registered a low of -$47.6 million during Q2 2025.
- In the last 3 years, Caribou Biosciences' Operating Income had a median value of -$38.2 million in 2024 and averaged -$36.6 million.
- Per our database at Business Quant, Caribou Biosciences' Operating Income tumbled by 607.94% in 2021 and then spiked by 44.86% in 2023.
- Quarterly analysis of 5 years shows Caribou Biosciences' Operating Income stood at -$20.4 million in 2021, then crashed by 49.86% to -$30.6 million in 2022, then fell by 22.45% to -$37.4 million in 2023, then decreased by 3.83% to -$38.9 million in 2024, then grew by 23.11% to -$29.4 million in 2025.
- Its Operating Income was -$29.4 million in Q3 2025, compared to -$47.6 million in Q2 2025 and -$42.9 million in Q1 2025.